United States

SPRAVATO® treatment in Greenville, US

2 listed treatment centers serving Greenville and the surrounding area.

Clinics in Greenville

SPRAVATO® cost and insurance in Greenville

Cost and insurance questions before starting

For people in Greenville considering SPRAVATO®, the total cost can involve more than the medication. Both the nasal spray and the treatment visit, including required observation and monitoring, may be billed. Ask for an explanation of these charges before scheduling, rather than assuming one quoted charge includes everything.

Coverage depends on your insurance plan and treatment setting. Prior authorization is common, and your insurer may request records of earlier antidepressant trials. Ask the treatment center which details it needs, such as medication names, treatment dates, doses, and your response. If records are held by previous prescribers, arranging their transfer early may help the review proceed.

Medicare coverage may fall under Part B or Part D, depending on the plan and setting. North Carolina Medicaid coverage also depends on the plan and setting. The two Greenville listings in this directory indicate that they do not accept Medicare or Medicaid; confirm current participation directly. That listing information does not establish whether your benefits cover treatment elsewhere.

Manufacturer savings programs exist for some eligible commercially insured patients, but not for people using government insurance. Ask about current eligibility rules and which charges any assistance applies to.

Before starting, ask the center and insurer:

  • Is this location in-network for both the medication and monitoring services?
  • Who submits prior authorization, and what records are required?
  • What deductible, copay, or coinsurance could apply to each billed service?
  • Does approval cover an initial course only, and how are later visits reviewed?
  • Can I receive a written estimate based on my benefits?

Neither a directory listing nor a benefits estimate guarantees coverage.

Planning travel for treatment in Greenville

Planning treatment visits from Greenville

SPRAVATO® visits require planning around both treatment and the trip home. Patients administer the nasal spray themselves under direct observation in a SPRAVATO® REMS-certified healthcare setting. It is never dispensed for home use. This directory lists two Greenville locations offering Spravato, but their REMS certification is not confirmed in the listing data. Verify certification directly before arranging treatment.

The typical labeled schedule begins with twice-weekly visits during weeks 1–4, followed by weekly visits during weeks 5–8. Maintenance visits may be weekly or every two weeks. Your prescriber will individualize the schedule, so do not assume a fixed number of appointments or a guaranteed reduction in visit frequency.

Expect each appointment to take at least about two hours, with monitoring lasting at least two hours after each dose. Check-in, preparation, and assessment before leaving can add time. When arranging work leave or caregiving, allow room for the full appointment and travel rather than budgeting only for the monitoring period.

You need someone else to take you home. You must not drive or operate machinery until the next day after a restful sleep. Arrange a reliable driver and a backup, and ask the center about its pickup and transportation requirements before booking rides.

If you cannot find an available Greenville center—or a directory search returns no local listing—other North Carolina cities with listed centers include Raleigh, Durham, Cary, and Wilmington. These are search options, not confirmed alternatives for your needs. Before committing to travel, verify REMS certification, appointment availability, insurance participation, and whether repeated trips fit your work and transportation plans.

SPRAVATO® treatment in Greenville: common questions

How do I find a certified Spravato center in Greenville?

This directory lists two Greenville locations offering SPRAVATO®, but their REMS certification is not confirmed in the listing data. Contact each location and ask whether it is currently certified to provide treatment through the REMS program. Also check whether it is accepting patients, can evaluate your needs, and participates in your insurance plan. A directory listing alone does not confirm those details.

Who may qualify for treatment?

Spravato is approved for adults with treatment-resistant depression, either alone or with an oral antidepressant. It is also approved, together with an oral antidepressant, for depressive symptoms in adults with major depressive disorder and acute suicidal thoughts or behavior. It is not approved for children. A clinician must review your diagnosis, treatment history, and safety considerations; meeting an approved indication does not automatically mean treatment is appropriate.

Will Medicare, North Carolina Medicaid, or my private insurance pay?

Coverage depends on your plan and treatment setting. Prior authorization and records of previous antidepressant trials are common requirements. Medicare or North Carolina Medicaid may cover treatment in some circumstances, but the two Greenville listings indicate that they do not accept these programs. Confirm current participation directly. Ask your insurer about both the medication and monitored visit, including network requirements and your share of the cost.

What happens during a treatment visit, and can I drive home?

You self-administer the nasal spray under a healthcare provider’s direct observation in a REMS-certified setting. Staff monitor you for at least two hours afterward for effects such as sedation, dissociation, breathing problems, and increased blood pressure. Allow additional time for preparation and assessment. Someone else must take you home, and you cannot drive or operate machinery until the next day after a restful sleep.

What side effects and safety risks should I discuss with the clinician?

Ask about sedation, dissociation—feeling disconnected from yourself or your surroundings—breathing problems, and blood pressure increases. Spravato carries boxed warnings for sedation, dissociation, respiratory depression, abuse and misuse, and suicidal thoughts and behaviors. It is a Schedule III controlled substance. Share your medical history, medications, and any substance-use concerns so the clinician can assess risks and explain monitoring.

Is Spravato a substitute for emergency care if I feel suicidal?

No. Although Spravato has an approved use for depressive symptoms in adults with major depressive disorder and acute suicidal thoughts or behavior, it has not been shown to prevent suicide or reduce suicidal thoughts or behavior. It does not replace hospitalization when needed. If you are in crisis, call or text 988. If there is immediate danger or a medical emergency, call 911 rather than waiting for a treatment appointment.

Nearby United States cities

Find a Provider